Eli Lilly bolstered its infectious diseases portfolio through acquisitions, while Qualcomm secured a $4 billion deal to supply chips for AI data centers.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly bolstered its infectious diseases portfolio through acquisitions, while Qualcomm secured a $4 billion deal to supply chips for AI data centers.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- ByteDance is actively headhunting top PhD candidates for tech giants, led by Jason Yang.Sub-event
Eli Lilly expands infectious disease portfolio via acquisitions; Qualcomm wins AI data center chip supply deal.1 source
Keep exploring
The entities involved
-
Modine
public company
Nothing else this week.
-
ByteDance
Chinese Internet and technology company
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Eli Lilly and Company announced agreements to acquire potential targets, filing reports with the SEC.
- Eli Lilly and Company plans to acquire Merida Biosciences for up to $2.8 billion in cash.
- Eli Lilly announced multiple new partnerships, including expanding Zepbound access with CVS Health, collaborating with Insilico Medicine, and investing in an AI lab with NVIDIA.